Preparation and Characterization of Calcium Phosphate Cement

Calcium phosphate cement (CPC) is one of the most
attractive bioceramics due to its moldable and shape ability to fill
complicated bony cavities or small dental defect positions. In this
study, CPC was produced by using mixture of tetracalcium phosphate
(TTCP, Ca4O(PO4)2) and dicalcium phosphate anhydrous (DCPA,
CaHPO4) in equimolar ratio (1/1) with aqueous solutions of acetic
acid (C2H4O2) and disodium hydrogen phosphate dehydrate
(Na2HPO4.2H2O) in combination with sodium alginate in order to
improve theirs moldable characteristic. The concentration of the
aqueous solutions and sodium alginate were varied to investigate the
effect of different aqueous solutions and alginate on properties of the
cements. The cement paste was prepared by mixing cement powder
(P) with aqueous solution (L) in a P/L ratio of 1.0g/0.35ml. X-ray
diffraction (XRD) was used to analyses phase formation of the
cements. Setting time and compressive strength of the set CPCs were
measured using the Gilmore apparatus and Universal testing
machine, respectively.
The results showed that CPCs could be produced by using both
basic (Na2HPO4.2H2O) and acidic (C2H4O2) solutions. XRD results
show the precipitation of hydroxyapatite in all cement samples. No
change in phase formation among cements using difference
concentrations of Na2HPO4.2H2O solutions. With increasing
concentration of acidic solutions, samples obtained less
hydroxyapatite with a high dicalcium phosphate dehydrate leaded to
a shorter setting time. Samples with sodium alginate exhibited higher
crystallization of hydroxyapatite than that of without alginate as a
result of shorten setting time in a basic solution but a longer setting
time in an acidic solution. The stronger cement was attained from
samples using the acidic solution with sodium alginate; however the
strength was lower than that of using the basic solution.

• W. Thepsuwan
• N. Monmaturapoj

• Calcium phosphate cements
• TTCP
• DCPA
• hydroxyapatite
• properties.

[1] C.D. Friedman, P.D. Costantino, S. Takagi, L.C. Chow, “Bone Source
hydroxyapatite cement: a novel biomaterial for craniofacial skeletal
tissue engineering and reconstruction,” J. Biomed. Mater. Res., Vol.
43,1998, pp. 428–432.
[2] D.B. Kamerer, B.E. Hirsch, C.H. Snyderman, P. Costantino, C.D.
Friedman, “Hydroxyapatite cement: a new method for achieving
watertight closure in transtemporal surgery,” Am. J. Otol., vol. 15, 1994,
pp. 47–49.
[3] B.R. Constantz, I.C. Ison, M.T. Fulmer, R.D. Poser, S.T. Smith, M.
VanWagoner,et al., “Skeletal repair by in situ formation of the mineral
phase of bone,” Science, vol 267, 1995, pp. 1796–1799.
[4] W.G. Horstmann, C.C.P.M. Verheyen, R. Leemans, “An injectable
calcium phosphate cement as a bone-graft substitute in the treatment of
displaced lateral tibial plateau fractures,” Injury, vol. 34, 2003, pp. 141–
144.
[5] E.J. Strauss, K.A. Egol, “The management of ankle fractures in the
elderly,” Injury, vol 38 (Suppl. 3), 2007, pp. S2–S9.
[6] P.A. Liverneaux, “Osteoporotic distal radius curettage—filling with an
injectable calcium phosphate cement. A cadaveric study,” Eur. J.
Orthop. Surg. Traumatol., vol. 15, 2004, pp. 1–6.
[7] R.D. Welch, H. Zhang, D.G. Bronson, “Experimental tibial plateau
fractures augmented with calcium phosphate cement or autologous bone
graft,” J. Bone Joint Surg., vol. 85, 2003, pp. 222.
[8] A. Aral, S. Yalçin, Z.C. Karabuda, A. Anil, J.A. Jansen, Z. Mutlu,
“Injectable calcium phosphate cement as a graft material for maxillary
sinus augmentation: an experimental pilot study,” Clin. Oral Implants
Res., vol. 19, 2008, pp. 612–617.
[9] [9] M.P. Ginebra, T. Traykova, J.A. Planell, “Calcium phosphate
cements: competitive drug carriers for the musculoskeletal system,”
Biomaterials, vol. 27, 2006, pp. 2171–2177.
[10] S. Hirayama, S. Hirayama, S. Takagi, M. Markovic, L.C. Chow,
Properties of calcium phosphate cements with different tetracalcium
phosphate and dicalcium phosphate anhydrous molar ratios, J. Res. Natl.
Inst. Stand. Technol., vol. 113, 2008, pp. 311–320.
[11] S. Hirayama, S. Takagi, M. Markovic, L.C. Chow, “Properties of
calcium phosphate cements with different tetracalcium phosphate and
dicalcium phosphate anhydrous molar ratios,” J. Res. Natl. Inst. Stand.
Technol., vol. 113, 2008, pp. 311–320.
[12] H. Suzuki, H. Suzuki, M. Sakurai, M. Watanabe, “The effect of
stimulator on hardening of calcium phosphates,” Phos. Res. Bull., vol.
12, 2001, pp. 31–38.
[13] K. Muroyama,T. Matumoto, K. Yamashita, T. Umegaki, “Effect of
addition of water-soluble polymers of hydraulically hardened calcium
phosphates,” Mukimateriaru, vol. 3, 1996, pp. 380–385.
[14] M. Watanabe, M. Tanaka, M. Sukurai, M. Maeda, “Development of
calcium phosphate cement,” J. Eur. Ceram. Soc., vol. 26, 2006, pp. 549–
552.
[15] S.Takagi, L.C.ChowandK.Ishikawa, “Formation of hydroxyapatite in
new calcium phosphate cements,” Biomaterial, vol. 19, 1998, pp. 1593-
1599.
[16] M.P. Ginebra, C. Canal, M. Espanol, D. Pastorino, E.B. Montufar,
“Calcium phosphate cements as drug delivery materials,” Adv. Drug
Deliv. Rev., vol. 64, 2012, pp. 1090–1110.
[17] F. C. M. Driessens, M. G. Boltong, O. Bermudez and J. A. Planell,
“Formulation and setting times of some calcium orthophosphate
cements: a pilot study,” J. Mater. Sci.: Mater. Med., vol. 4, 1993, pp.
503-508.
[18] F. C. M. Driessens, J.A. Planell,M.G. Boltong, I. Khairoun and M.P.
Ginebra, J. Eng. Med., “Proceedings of the Institution of Mechanical
Engineers, Part H,” 1998, pp. 212-427.